Short research peptide

Pinealon

Pinealon has been investigated in cell-viability and oxidative-stress experiments. These laboratory findings do not establish human outcomes.

Quantity per vial

Select variantCompare prices and choose a variant to set the quantity and add it to your quote.

Subtotal excludes freight and taxes. Availability and final terms are confirmed in the quote. Commercial and shipping terms

Mechanism and findings

In vitro · Study formulation · Cultured neural and immune cells

Oxidative stress response

Cellular experiments examined reactive oxygen species, cell death and ERK signaling; these are not human clinical outcomes.

Khavinson et al., 2011 →

Literature findings; refer to the model and formulation studied.

Mechanism of action

Pinealon — short research peptide. The literature identity must be matched to the documented chemical form and composition of the supplied material.

Assays related reactive oxygen species accumulation, cell death and ERK1/2 activation. Responses depended on concentration and cellular system. Cell-cycle changes were examined but do not establish clinical efficacy for cognition or aging.

  • Cellular oxidative stress

Khavinson et al., 2011

Studied findings 1
In vitro · Study formulation

Oxidative stress response

Cultured neural and immune cells

Cellular experiments examined reactive oxygen species, cell death and ERK signaling; these are not human clinical outcomes.

View context
Study design
Original-study abstract; experimental design described in linked source
Sample scope / arm
Not extracted; consult original study
Comparator
See original-study context
Experimental context (not instructions for use)
Abstract-level extraction; full methods and tables still require review.
Source section / table / abstract
Abstract

Evidence concerns the studied material and model, not the supplied BLOPEP batch.

Khavinson et al., 2011

Sources and studies 2
  1. Pinealon — PubChem molecular identity

  2. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes.

    Khavinson V, Ribakova Y, Kulebiakin K, Vladychenskaya E, Kozina L, Arutjunyan A, Boldyrev A · 2011 · Rejuvenation research

    DOI: 10.1089/rej.2011.1172

Specifications and packaging

Nominal variant content; analytical results belong to the documented batch.

Material type
Peptide
Molecular formula (literature identity)
C15H26N6O8
Molecular weight (literature identity)
418.40 g/mol

Quality and analyses

Review specifications, analytical results and documentation for published batches.

Purity
>99%
Type
Declared specification

Published batches

Batch results have not yet been published on this page.

Storage

Consult the specific conditions in the supplied material documentation.

Delivery and commercial terms

Freight, timing and import terms will be confirmed in the quote for the selected destination.